Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interstitial Laser Thermotherapy (imILT) as a Treatment Option in Breast Cancer Patients Not Suitable for Surgical Excision

NCT03039127 is registered in ClinicalTrials.gov with Clinical Laserthermia Systems AB as lead sponsor.

NCT NCT03039127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03039127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interstitial Laser Thermotherapy (imILT) as a Treatment Option in Breast Cancer Patients Not Suitable for Surgical Excision
Lead sponsor
Clinical Laserthermia Systems AB
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2016
Completion date
August 31, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms